{"date":"2026-03-03","count":82,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7427-2026-03-03-2251-11b1948","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-03","time":"22:51:13","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-03-03 22:51，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2026-03-03-2240-6r49ey","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-03","time":"22:40:59","subject":"公告本公司董事會決議虧損撥補案暨不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-03-03 22:40，「公告本公司董事會決議虧損撥補案暨不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2026-03-03-2221-12of6u4","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-03","time":"22:21:49","subject":"公告本公司114年度累積虧損達實收資本額二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-03-03 22:21，「公告本公司114年度累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2026-03-03-2220-1xl66gd","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-03","time":"22:20:49","subject":"公告本公司董事會通過114年度個別財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-03-03 22:20，「公告本公司董事會通過114年度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2026-03-03-2219-84656m","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-03","time":"22:19:47","subject":"公告本公司董事會通過內部稽核主管任命案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-03-03 22:19，「公告本公司董事會通過內部稽核主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2026-03-03-2219-1m05xnn","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-03","time":"22:19:06","subject":"公告本公司董事會通過財務主管、會計主管及代理發言人任命案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-03-03 22:19，「公告本公司董事會通過財務主管、會計主管及代理發言人任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2026-03-03-2204-1xu0c7w","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2026-03-03","time":"22:04:03","subject":"公告本公司董事會決議115年股東常會召開事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2026-03-03 22:04，「公告本公司董事會決議115年股東常會召開事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2026-03-03-2153-11wjw0o","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2026-03-03","time":"21:53:57","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2026-03-03 21:53，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1813-2026-03-03-2143-1ctgck9","company_id":"1813","company":"寶利徠","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"21:43:23","subject":"本公司董事會決議不分派股利","clause":"第14款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：寶利徠（1813），2026-03-03 21:43，「本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1813-2026-03-03-2139-163mvu1","company_id":"1813","company":"寶利徠","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"21:39:45","subject":"依『公開發行公司資金貸與及背書保證處理準則』第二十二條第一項第三款公告","clause":"第23款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：寶利徠（1813），2026-03-03 21:39，「依『公開發行公司資金貸與及背書保證處理準則』第二十二條第一項第三款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1813-2026-03-03-2139-148iap7","company_id":"1813","company":"寶利徠","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"21:39:20","subject":"本公司董事會決議召開股東會事宜","clause":"第17款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：寶利徠（1813），2026-03-03 21:39，「本公司董事會決議召開股東會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1813-2026-03-03-2138-5j9yh6","company_id":"1813","company":"寶利徠","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"21:38:18","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：寶利徠（1813），2026-03-03 21:38，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2026-03-03-2136-o5veqf","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2026-03-03","time":"21:36:39","subject":"公告本公司董事會通過財務主管、公司治理主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2026-03-03 21:36，「公告本公司董事會通過財務主管、公司治理主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2026-03-03-2134-1hds7fq","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2026-03-03","time":"21:34:27","subject":"公告本公司董事會通過114年第四季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2026-03-03 21:34，「公告本公司董事會通過114年第四季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6844-2026-03-03-2102-jq4j30","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"21:02:36","subject":"公告本公司董事會決議召開民國115年股東常會相關事宜","clause":"第17款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2026-03-03 21:02，「公告本公司董事會決議召開民國115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6844-2026-03-03-2101-1o98txl","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"21:01:21","subject":"公告本公司董事會決議辦理現金增資私募普通股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2026-03-03 21:01，「公告本公司董事會決議辦理現金增資私募普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6844-2026-03-03-2100-1epk9i","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"21:00:52","subject":"公告本公司董事會決議不繼續辦理114年股東會通過之私募普通股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2026-03-03 21:00，「公告本公司董事會決議不繼續辦理114年股東會通過之私募普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6844-2026-03-03-2100-1ioo9mj","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"21:00:26","subject":"公告本公司董事會決議股利分派暨資本公積發放現金","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2026-03-03 21:00，「公告本公司董事會決議股利分派暨資本公積發放現金」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6844-2026-03-03-2059-5j9yh6","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"20:59:41","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2026-03-03 20:59，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6844-2026-03-03-2057-6y5xdu","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"20:57:00","subject":"公告本公司董事會通過114年度員工酬勞及董事酬勞分派案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2026-03-03 20:57，「公告本公司董事會通過114年度員工酬勞及董事酬勞分派案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-03-03-2031-1xlintx","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-03-03","time":"20:31:38","subject":"公告本公司114年度合併財務報告董事會預計召開日期為115年3月12日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-03-03 20:31，「公告本公司114年度合併財務報告董事會預計召開日期為115年3月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6649-2026-03-03-1839-11wjw0o","company_id":"6649","company":"台生材","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"18:39:00","subject":"公告本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：台生材（6649），2026-03-03 18:39，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-03-03-1835-d6usp8","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"18:35:40","subject":"本公司董事會決議發行國內第八次無擔保轉換公司債暨第九次無擔保轉換公司債","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-03-03 18:35，「本公司董事會決議發行國內第八次無擔保轉換公司債暨第九次無擔保轉換公司債」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6649-2026-03-03-1835-11b1948","company_id":"6649","company":"台生材","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"18:35:32","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第17款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：台生材（6649），2026-03-03 18:35，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6649-2026-03-03-1828-1b89la1","company_id":"6649","company":"台生材","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"18:28:44","subject":"公告本公司董事會通過114年度財務報告","clause":"第31款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：台生材（6649），2026-03-03 18:28，「公告本公司董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-03-03-1827-1i28jm4","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"18:27:59","subject":"公告本公司董事會決議參與認購子公司豐華生物科技(股)公司現金增資普通股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-03-03 18:27，「公告本公司董事會決議參與認購子公司豐華生物科技(股)公司現金增資普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-03-03-1811-kcrxyx","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"18:11:24","subject":"本公司董事會決議解除經理人競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-03-03 18:11，「本公司董事會決議解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-03-03-1807-fqsc9p","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"18:07:22","subject":"本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-03-03 18:07，「本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2026-03-03-1801-1dq26jx","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"18:01:32","subject":"公告本公司114年度個體暨合併財務報告董事會預計召開日期為115年03月11日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2026-03-03 18:01，「公告本公司114年度個體暨合併財務報告董事會預計召開日期為115年03月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2026-03-03-1800-sjl8ul","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2026-03-03","time":"18:00:11","subject":"公告本公司114年度合併財務報告董事會召開日期","clause":"第31款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2026-03-03 18:00，「公告本公司114年度合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6547-2026-03-03-1752-1etdr8s","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"17:52:49","subject":"公告本公司董事會決議召開115年股東常會日期及相關事宜","clause":"第17款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2026-03-03 17:52，「公告本公司董事會決議召開115年股東常會日期及相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6547-2026-03-03-1751-1mvy42n","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"17:51:44","subject":"公告本公司董事會決議股利分派情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2026-03-03 17:51，「公告本公司董事會決議股利分派情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2026-03-03-1751-sjl8ul","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"17:51:21","subject":"公告本公司114年度合併財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2026-03-03 17:51，「公告本公司114年度合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6547-2026-03-03-1751-5j9yh6","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"17:51:07","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2026-03-03 17:51，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4148-2026-03-03-1729-f9rxoy","company_id":"4148","company":"全宇生技-KY","market":"上市","industry":"生技醫療","date":"2026-03-03","time":"17:29:16","subject":"代子公司SSHF公告董事會決議股利分配","clause":"第14款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：全宇生技-KY（4148），2026-03-03 17:29，「代子公司SSHF公告董事會決議股利分配」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2026-03-03-1720-1yvri0z","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"17:20:30","subject":"公告本公司新聘任竹北廠廠長","clause":"第8款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-03-03 17:20，「公告本公司新聘任竹北廠廠長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2026-03-03-1717-riucas","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"17:17:48","subject":"公告本公司董事會決議召開民國一一五年股東常會","clause":"第17款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-03-03 17:17，「公告本公司董事會決議召開民國一一五年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2026-03-03-1712-p5b63k","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"17:12:01","subject":"公告本公司不發放股利","clause":"第14款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-03-03 17:12，「公告本公司不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2026-03-03-1709-5j9yh6","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"17:09:20","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-03-03 17:09，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-03-03-1708-5j9yh6","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"17:08:14","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-03-03 17:08，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2026-03-03-1704-gi3647","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"17:04:54","subject":"公告本公司董事會決議買回庫藏股事宜","clause":"第35款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-03-03 17:04，「公告本公司董事會決議買回庫藏股事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4120-2026-03-03-1700-14q2vvq","company_id":"4120","company":"友華","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"17:00:27","subject":"代重要子公司友杏生技(股)公司公告董事會決議召開一一五年股東常會","clause":"第17款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：友華（4120），2026-03-03 17:00，「代重要子公司友杏生技(股)公司公告董事會決議召開一一五年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4120-2026-03-03-1700-1l7e1wl","company_id":"4120","company":"友華","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"17:00:17","subject":"代重要子公司友杏生技(股)公司公告董事會決議不分派股利","clause":"第14款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：友華（4120），2026-03-03 17:00，「代重要子公司友杏生技(股)公司公告董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7832-2026-03-03-1657-dd4a6e","company_id":"7832","company":"智新生技*","market":"興櫃","industry":"生技醫療","date":"2026-03-03","time":"16:57:20","subject":"公告本公司受邀參加環球生技與藥時事共同舉辦之全球生技醫藥催化拐點高峰論壇","clause":"第30款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：智新生技*（7832），2026-03-03 16:57，「公告本公司受邀參加環球生技與藥時事共同舉辦之全球生技醫藥催化拐點高峰論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4131-2026-03-03-1653-f7zdi0","company_id":"4131","company":"浩泰","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"16:53:44","subject":"公告本公司114年度財務報告董事會召開日期","clause":"第31款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：浩泰（4131），2026-03-03 16:53，「公告本公司114年度財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2026-03-03-1653-rsdz8","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2026-03-03","time":"16:53:00","subject":"公告本公司授權夥伴向智利公共衛生研究院(ISP)申請眼部術後炎症和疼痛治療新藥APP13007上市查驗登記","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2026-03-03 16:53，「公告本公司授權夥伴向智利公共衛生研究院(ISP)申請眼部術後炎症和疼痛治療新藥APP13007上市查驗登記」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2026-03-03-1651-snnsqw","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"16:51:40","subject":"公告本公司董事會決議分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2026-03-03 16:51，「公告本公司董事會決議分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-03-03-1648-1hu3cbe","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-03-03","time":"16:48:56","subject":"本公司董事會決議召開115年股東常會事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-03-03 16:48，「本公司董事會決議召開115年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2026-03-03-1647-1ar2i4r","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2026-03-03","time":"16:47:56","subject":"公告本公司114年度現金增資催繳期間屆滿暨股票發放事宜","clause":"第51款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2026-03-03 16:47，「公告本公司114年度現金增資催繳期間屆滿暨股票發放事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2026-03-03-1635-1xl66gd","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"16:35:31","subject":"公告本公司董事會通過114年度個別財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2026-03-03 16:35，「公告本公司董事會通過114年度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2026-03-03-1635-bf8m0l","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"16:35:15","subject":"公告本公司114年度財務報告董事會預計召開日期為115年03月11日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2026-03-03 16:35，「公告本公司114年度財務報告董事會預計召開日期為115年03月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6598-2026-03-03-1633-dgtqdi","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2026-03-03","time":"16:33:32","subject":"公告114年第四季財務報告董事會召開日期","clause":"第31款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2026-03-03 16:33，「公告114年第四季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2026-03-03-1632-p1hg67","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"16:32:56","subject":"本公司收到授權夥伴Accord Healthcare通知，前列腺癌新劑型新藥 CAMCEVI 三個月劑型獲EMA人體用藥品委員會(CHMP) 建議上市許可之正面意見","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2026-03-03 16:32，「本公司收到授權夥伴Accord Healthcare通知，前列腺癌新劑型新藥 CAMCEVI 三個月劑型獲EMA人體用藥」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2026-03-03-1632-19l097s","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"16:32:02","subject":"智擎生技製藥(股)公司董事會決議召開115年股東常會公告","clause":"第17款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2026-03-03 16:32，「智擎生技製藥(股)公司董事會決議召開115年股東常會公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-03-03-1628-t7qizt","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-03-03","time":"16:28:30","subject":"公告本公司董事會通過不分派114年度員工酬勞及董事酬勞","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-03-03 16:28，「公告本公司董事會通過不分派114年度員工酬勞及董事酬勞」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-03-03-1627-bwopfv","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-03-03","time":"16:27:52","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-03-03 16:27，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2026-03-03-1626-92x690","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"16:26:51","subject":"董事會決議股利分派","clause":"第14款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2026-03-03 16:26，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2026-03-03-1626-11b1948","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"16:26:07","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2026-03-03 16:26，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2026-03-03-1624-1q5ggyx","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"16:24:29","subject":"公告本公司114年第四季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2026-03-03 16:24，「公告本公司114年第四季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-03-03-1624-1i87q9m","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-03-03","time":"16:24:23","subject":"公告本公司董事會通過114年度財報","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-03-03 16:24，「公告本公司董事會通過114年度財報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2026-03-03-1619-1isel36","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"16:19:31","subject":"公告本公司114年度個別財務報告","clause":"第31款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2026-03-03 16:19，「公告本公司114年度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-03-03-1618-1q5ggyx","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-03-03","time":"16:18:39","subject":"公告本公司114年第四季合併財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-03-03 16:18，「公告本公司114年第四季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2026-03-03-1617-1rkgxjt","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"16:17:37","subject":"更正本公司114年12月營收及114年1-12月累計營收公告","clause":"第53款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2026-03-03 16:17，「更正本公司114年12月營收及114年1-12月累計營收公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4737-2026-03-03-1549-19nw1jv","company_id":"4737","company":"華廣","market":"上市","industry":"生技醫療","date":"2026-03-03","time":"15:49:24","subject":"公告本公司114年度財務報告董事會預計召開日期為115年3月11日","clause":"第31款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：華廣（4737），2026-03-03 15:49，「公告本公司114年度財務報告董事會預計召開日期為115年3月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2026-03-03-1546-11wjw0o","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2026-03-03","time":"15:46:47","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2026-03-03 15:46，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2026-03-03-1543-1i6pcrb","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2026-03-03","time":"15:43:36","subject":"本公司受邀參加統一證券舉辦之2026Q1全球展望春季投資論壇","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2026-03-03 15:43，「本公司受邀參加統一證券舉辦之2026Q1全球展望春季投資論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-03-03-1543-5f54ui","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-03-03","time":"15:43:27","subject":"本公司將於115年3月9日召開上市前業績發表會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-03-03 15:43，「本公司將於115年3月9日召開上市前業績發表會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2026-03-03-1536-jmsbi0","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"15:36:31","subject":"公告本公司114年度財務報告之董事會預計召開日期為115年3月11日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2026-03-03 15:36，「公告本公司114年度財務報告之董事會預計召開日期為115年3月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6955-2026-03-03-1523-1howjn","company_id":"6955","company":"邦睿生技-創","market":"上市","industry":"生技醫療","date":"2026-03-03","time":"15:23:09","subject":"公告本公司董事會決議召開115年股東常會","clause":"第17款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：邦睿生技-創（6955），2026-03-03 15:23，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6955-2026-03-03-1522-1orm707","company_id":"6955","company":"邦睿生技-創","market":"上市","industry":"生技醫療","date":"2026-03-03","time":"15:22:51","subject":"公告本公司董事會決議盈餘暨資本公積轉增資發行新股案","clause":"第11款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：邦睿生技-創（6955），2026-03-03 15:22，「公告本公司董事會決議盈餘暨資本公積轉增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6955-2026-03-03-1522-11wjw0o","company_id":"6955","company":"邦睿生技-創","market":"上市","industry":"生技醫療","date":"2026-03-03","time":"15:22:34","subject":"公告本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：邦睿生技-創（6955），2026-03-03 15:22，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6955-2026-03-03-1522-e6hr0k","company_id":"6955","company":"邦睿生技-創","market":"上市","industry":"生技醫療","date":"2026-03-03","time":"15:22:16","subject":"公告本公司董事會通過114年度合併財務報表","clause":"第31款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：邦睿生技-創（6955），2026-03-03 15:22，「公告本公司董事會通過114年度合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-03-03-1522-krq5j4","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"15:22:06","subject":"本公司已正式與由Y Combinator（W26）支持、其核心技術源自耶魯大學研究之 AI 驅動生物醫學公司CellType簽署策略性合作備忘錄（MOU）。生華科將成為其創始合作夥伴深化全面性合作","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-03-03 15:22，「本公司已正式與由Y Combinator（W26）支持、其核心技術源自耶魯大學研究之 AI 驅動生物醫學公司CellTy」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6955-2026-03-03-1521-3141u0","company_id":"6955","company":"邦睿生技-創","market":"上市","industry":"生技醫療","date":"2026-03-03","time":"15:21:52","subject":"公告本公司董事會決議114年度員工酬勞及董事酬勞分派案","clause":"第51款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：邦睿生技-創（6955），2026-03-03 15:21，「公告本公司董事會決議114年度員工酬勞及董事酬勞分派案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-03-03-1519-186731r","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-03-03","time":"15:19:00","subject":"受邀參加統一證券2026 Q1全球展望春季投資論壇","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-03-03 15:19，「受邀參加統一證券2026 Q1全球展望春季投資論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2026-03-03-1507-v074xa","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"15:07:52","subject":"公告本公司114年度財務報告預計提報董事會召開日期為115年03月11日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2026-03-03 15:07，「公告本公司114年度財務報告預計提報董事會召開日期為115年03月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2026-03-03-1454-1ejkgl7","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2026-03-03","time":"14:54:37","subject":"本公司董事會決議召開民國115年股東常會公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2026-03-03 14:54，「本公司董事會決議召開民國115年股東常會公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2026-03-03-1453-ybihnz","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2026-03-03","time":"14:53:40","subject":"睿生光電114年第四季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2026-03-03 14:53，「睿生光電114年第四季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-03-03-1439-19nw1jv","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"14:39:52","subject":"公告本公司114年度財務報告董事會預計召開日期為115年3月11日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-03-03 14:39，「公告本公司114年度財務報告董事會預計召開日期為115年3月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4142-2026-03-03-1431-4g044h","company_id":"4142","company":"國光生","market":"上市","industry":"生技醫療","date":"2026-03-03","time":"14:31:44","subject":"公告本公司民國114年度財務報告提報董事會召開日期","clause":"第31款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：國光生（4142），2026-03-03 14:31，「公告本公司民國114年度財務報告提報董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-03-03-1351-hao8v8","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-03-03","time":"13:51:16","subject":"代子公司「蘇州中化藥品工業有限公司」公告其董事會決議不發放114年度股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-03-03 13:51，「代子公司「蘇州中化藥品工業有限公司」公告其董事會決議不發放114年度股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-03-03-1348-19nw1jv","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-03-03","time":"13:48:06","subject":"公告本公司114年度財務報告董事會預計召開日期為115年3月11日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-03-03 13:48，「公告本公司114年度財務報告董事會預計召開日期為115年3月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}